查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576529

抗體生產市場：按產品、抗體、來源、製程 - 到 2031 年的全球預測

Antibody Production Market by Product, Antibody, Source, Process - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 200 Pages | 商品交期: 5-7個工作天內

價格

預計到 2031 年，抗體生產市場將達到 583.5 億美元，2024 年至 2031 年的複合年增長率為 11.4%。在進行二次和初步研究並詳細分析市場情景後，我們討論了主要的行業推動因素、市場限制、市場機會、市場推動因素/課題和趨勢。

抗體生產市場的成長是由對標靶抗體的需求增加、製藥和生物技術公司研發投資增加、癌症和自體免疫疾病盛行率增加、免疫測定法使用增加以及製程技術進步所帶來的推動。然而，抗體生產的高成本和嚴格的監管框架限制了市場的成長。

此外，抗體在臨床試驗和醫學研究中的廣泛使用、其在發展中國家的巨大潛力以及傳染病風險和患病率的增加預計將為在該市場運營的公司提供成長機會。然而，單株抗體的複雜性給市場利害關係人帶來了課題。

目錄

第 1 章概述

第2章研究方法

第 3 章執行摘要

第 4 章市場洞察

  • 摘要
  • 市場成長因素
    • 市場動態
      • 促進因素
        • 對標靶抗體的需求不斷增加
        • 製藥和生技公司增加研發投資
        • 癌症和自體免疫疾病的負擔沉重且盛行率不斷上升
        • 增加免疫分析的使用
        • 生物製程技術的進步
      • 阻礙因素
        • 抗體生產成本高
        • 嚴格的監理框架
      • 機會
        • 擴大抗體在臨床試驗和醫學研究的使用
        • 新興國家的巨大機遇
        • 傳染病的風險和傳播增加
      • 課題
        • 單株抗體的複雜特性
  • 監理分析
  • 波特五力分析
  • 價格分析

第5章抗體生產市場評估：依產品

  • 摘要
  • 設備
    • 生物反應器
      • 可重複使用的生物反應器
      • 一次性生物反應器
    • 色譜系統
    • 過濾系統
    • 其他設備
  • 消耗品
    • 細胞株/培養基
    • 緩衝液/試劑
    • 色譜管/樹脂
    • 其他消耗品
  • 軟體

第6章抗體生產市場：以抗體類型評估

  • 摘要
  • 單株抗體
  • 多株抗體
  • 重組抗體

第7章抗體生產市場評估：依來源

  • 摘要
  • 滑鼠
  • 兔子
  • 其他來源

第 8 章抗體生產市場評估：依流程

  • 摘要
  • 下游流程
  • 上游流程

第 9 章抗體生產市場評估：依最終使用者

  • 摘要
  • 製藥/生物公司
  • CRO□CDMO
  • 學術/研究機構

第10章抗體生產市場評估：依地區

  • 摘要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 中東/非洲

第11章競爭分析

  • 摘要
  • 主要成長策略
  • 競爭基準測試
  • 競爭對手儀表板
    • 行業領導者
    • 市場差異化因素
    • 前衛公司
    • 新興公司
  • 主要企業市佔率分析/市場排名（2022年）

第12章公司簡介（業務概況、財務概況、產品組合、策略發展狀況）

  • Thermo Fisher Scientific, Inc.
  • Merck KgaA
  • Eppendorf SE
  • Agilent Technologies, Inc.
  • Sartorius AG
  • Danaher Corporation
  • Waters Corporation
  • Shimadzu Corporation
  • Solaris Biotechnology Srl
  • Infors AG

（註：預定提供上位5公司之SWOT分析）

第13章 附錄

Product Code: MRHC - 1041086

Antibody Production Market by Product [Bioreactors (Single-use, Reusable), Chromatography, Filtration, Cell Lines, Media, Buffers, Resins], Antibody [Monoclonal, Polyclonal], Source [Mice, Rabbit], Process [Downstream, Upstream] - Global Forecast to 2031

The antibody production market is projected to reach $58.35 billion by 2031, at a CAGR of 11.4% from 2024 to 2031. After secondary and primary research and an in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, opportunities, challenges, and trends.

The growth of the antibody production market is driven by the growing demand for targeted antibodies, increasing investments in R&D by pharma & biotech companies, the growing prevalence of cancer and autoimmune diseases, the increasing use of immunoassays, and advancements in bioprocessing technologies. However, the high costs of antibody production and stringent regulatory frameworks restrain the growth of this market.

Furthermore, the growing applications of antibodies in clinical trials and medical research, significant potential in developing countries, and the growing risk and prevalence of infectious diseases are expected to generate growth opportunities for the players operating in this market. However, the complex nature of monoclonal antibodies is a challenge for market stakeholders.

Based on product, the antibody production market is segmented into instruments, consumables, and software. In 2024, the instruments segment is expected to account for the largest share of the antibody production market. The need for high-volume and scalable production of antibodies for commercial use, the need for separation, purification, and isolation of antibodies, and the growing need for mass production of antibodies for therapeutic applications are major factors contributing to the segment's large share.

Based on antibody type, the antibody production market is segmented into monoclonal antibodies, polyclonal antibodies, antibody segments, and recombinant antibodies. The monoclonal antibodies segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the growing applications of monoclonal antibodies in the treatment of diseases and disorders, the growing use of monoclonal antibodies for cancer treatment, and the increasing focus of pharmaceutical & biotechnology companies on the development of monoclonal antibody-based therapeutics.

Based on source, the antibody production market is segmented into mice, rabbits, and other sources. In 2024, the mice segment is expected to account for the largest share of the antibody production market. Due to the availability, low cost, and quick production time for mouse mAbs, humanization of mouse mAbs has been implemented on a large scale. Furthermore, mouse husbandry is easier than rabbit husbandry, and the genetic approaches to engineering antibodies through recombinant technologies are more established for mice than for other animals, such as rabbits, making mice a preferred choice for antibody production.

Based on process, the antibody production market is segmented into upstream and downstream. In 2024, the downstream segment is expected to account for the larger share of the antibody production market. The segment's large share can be attributed to the high preference for downstream processing as it is used for the recovery and purification of biosynthetic products, including antibodies from natural sources such as animal or plant tissue or fermentation broth, including the recycling of salvageable components and the proper treatment and disposal of waste.

Based on end user, the antibody production market is segmented into pharmaceutical & biotechnology companies, clinical research organizations & contract development & manufacturing organizations, and other end users. The pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is driven by the expansion of antibody manufacturing facilitates, increasing R&D investments by pharma & biotech companies, the growing prevalence of chronic & infectious diseases, and the need to develop antibody-based therapeutics for these diseases. In addition, initiatives by pharma and biotech companies to launch antibody-based therapeutics are further expected to drive the segment's growth.

An in-depth analysis of the geographical scenario in the antibody production market provides detailed qualitative and quantitative insights about five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the antibody production market, followed by Europe and Asia-Pacific. Technological advancements in bioprocessing, the high number of industry-academia collaborations for research & development of antibodies, the high prevalence of chronic diseases, and the high demand for biologics are expected to support North America's largest share.

The key companies operating in the antibody production market include Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KgaA (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), Danaher Corporation (U.S.), Waters Corporation (U.S.), Shimadzu Corporation (Japan), Solaris Biotechnology Srl (Italy), and Infors AG (Switzerland).

Scope of the Report:

Antibody Production Market Assessment-by Product

  • Instruments
    • Bioreactors
  • Single-use Bioreactors
  • Reusable Bioreactors
    • Chromatography Systems
    • Filtration Systems
    • Other Instruments

(Note: Other instruments include shakers, mixers, incubators, sterilizers, centrifuges, and bioprocessing containers.)

  • Consumables
    • Cell Lines & Media
    • Buffers & Reagents
    • Chromatography Columns & Resins
    • Other Consumables

(Note: Other consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors.)

  • Software

Antibody Production Market Assessment-by Antibody Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies

Antibody Production Market Assessment-by Source

  • Mice
  • Rabbits
  • Other Sources

(Note: Other sources include goats, sheep, and chicken.)

Antibody Production Market Assessment-by Process

  • Downstream
  • Upstream

Antibody Production Market Assessment-by End User

  • Pharmaceutical & Biotechnology Companies
  • Clinical Research Organizations & Contract Development & Manufacturing Organizations
  • Academic & Research Institutes

Antibody Production Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Overview

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions For the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Market Dynamics
      • 4.2.1.1. Drivers
        • 4.2.1.1.1. Growing Demand for Targeted Antibodies
        • 4.2.1.1.2. Increasing Investments In R&D By Pharma & Biotech Companies
        • 4.2.1.1.3. High Burden and Growing Prevalence of Cancer and Autoimmune Diseases
        • 4.2.1.1.4. Increasing Use of Immunoassays
        • 4.2.1.1.5. Advancements In Bioprocessing Technologies
      • 4.2.1.2. Restraints
        • 4.2.1.2.1. High Cost of Antibody Production
        • 4.2.1.2.2. Stringent Regulatory Frameworks
      • 4.2.1.3. Opportunities
        • 4.2.1.3.1. Growing Applications of Antibodies in Clinical Trials and Medical Research
        • 4.2.1.3.2. Significant Opportunities from Developing Countries.
        • 4.2.1.3.3. Growing Risk and Prevalence of Infectious Diseases
      • 4.2.1.4. Challenges
        • 4.2.1.4.1. Complex Nature of Monoclonal Antibodies
  • 4.3. Regulatory Analysis
  • 4.4. Porter's Five Forces Analysis
  • 4.5. Pricing Analysis

5. Antibody Production Market Assessment-by Product

  • 5.1. Overview
  • 5.2. Instruments
    • 5.2.1. Bioreactors
      • 5.2.1.1. Reusable Bioreactors
      • 5.2.1.2. Single-use Bioreactors
    • 5.2.2. Chromatography Systems
    • 5.2.3. Filtration Systems
    • 5.2.4. Other Instruments
  • 5.3. Consumables
    • 5.3.1. Cell Lines & Media
    • 5.3.2. Buffers & Reagents
    • 5.3.3. Chromatography Columns & Resins
    • 5.3.4. Other Consumables
  • 5.4. Software

6. Antibody Production Market Assessment-by Antibody Type

  • 6.1. Overview
  • 6.2. Monoclonal Antibodies
  • 6.3. Polyclonal Antibodies
  • 6.4. Recombinant Antibodies

7. Antibody Production Market Assessment-by Source

  • 7.1. Overview
  • 7.2. Mice
  • 7.3. Rabbit
  • 7.4. Other Sources

8. Antibody Production Market Assessment-by Process

  • 8.1. Overview
  • 8.2. Downstream
  • 8.3. Upstream

9. Antibody Production Market Assessment-by End User

  • 9.1. Overview
  • 9.2. Pharmaceutical & Biotechnology Companies
  • 9.3. CROs & CDMOs
  • 9.4. Academic & Research Institutes

10. Antibody Production Market Assessment-by Geography

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. China
    • 10.4.2. India
    • 10.4.3. Japan
    • 10.4.4. Rest of Asia-Pacific
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America
  • 10.6. Middle East & Africa

11. Competition Analysis

  • 11.1. Overview
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
  • 11.4. Competitive Dashboard
    • 11.4.1. Industry Leaders
    • 11.4.2. Market Differentiators
    • 11.4.3. Vanguards
    • 11.4.4. Emerging Companies
  • 11.5. Market Share Analysis/Market Ranking, by Key Players (2022)

12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 12.1. Thermo Fisher Scientific, Inc.
  • 12.2. Merck KgaA
  • 12.3. Eppendorf SE
  • 12.4. Agilent Technologies, Inc.
  • 12.5. Sartorius AG
  • 12.6. Danaher Corporation
  • 12.7. Waters Corporation
  • 12.8. Shimadzu Corporation
  • 12.9. Solaris Biotechnology Srl
  • 12.10. Infors AG

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

13. Appendix

  • 13.1. Available Customization
  • 13.2. Related Reports

LIST OF TABLES

  • Table 1 Global Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 2 Global Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 3 Global Antibody Production Instruments Market, By Country/Region, 2022-2031 (USD Million)
  • Table 4 Global Bioreactors Market for Antibody Production, By Type, 2022-2031 (USD Million)
  • Table 5 Global Bioreactors Market for Antibody Production, By Country/Region, 2022-2031 (USD Million)
  • Table 6 Global Reusable Bioreactors Market for Antibody Production, By Country/Region, 2022-2031 (USD Million)
  • Table 7 Global Single-use Bioreactors Market for Antibody Production, By Country/Region, 2022-2031 (USD Million)
  • Table 8 Global Filtration Systems Market for Antibody Production, By Country/Region, 2022-2031 (USD Million)
  • Table 9 Global Chromatography Systems Market for Antibody Production, By Country/Region, 2022-2031 (USD Million)
  • Table 10 Global Other Instruments Market for Antibody Production, By Country/Region, 2022-2031 (USD Million)
  • Table 11 Global Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 12 Global Antibody Production Consumables Market, By Country/Region, 2022-2031 (USD Million)
  • Table 13 Global Cell Lines & Media Market, By Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Buffers & Reagents Market, By Country/Region, 2022-2031 (USD Million)
  • Table 15 Global Chromatography Columns & Resins Market, By Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Other Antibody Production Consumables Market, By Country/Region, 2022-2031 (USD Million)
  • Table 17 Global Antibody Production Software Market, By Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 19 Global Monoclonal Antibodies Production Market, By Country/Region, 2022-2031 (USD Million)
  • Table 20 Global Polyclonal Antibodies Production Market, By Country/Region, 2022-2031 (USD Million)
  • Table 21 Global Recombinant Antibodies Production Market, By Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 23 Global Antibody Production Market for Mice, By Country/Region, 2022-2031 (USD Million)
  • Table 24 Global Antibody Production Market for Rabbit, By Country/Region, 2022-2031 (USD Million)
  • Table 25 Global Antibody Production Market for Other Sources, By Country/Region, 2022-2031 (USD Million)
  • Table 26 Global Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 27 Global Antibody Production Market for Downstream Process, By Country/Region, 2022-2031 (USD Million)
  • Table 28 Global Antibody Production Market for Upstream Process, By Country/Region, 2022-2031 (USD Million)
  • Table 29 Global Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 30 Global Antibody Production Market for Pharmaceutical & Biotechnology Companies, By Country/Region, 2022-2031 (USD Million)
  • Table 31 Global Antibody Production Market for CROs & CDMOs, By Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Antibody Production Market for Academic & Research Institutes, By Country/Region, 2022-2031 (USD Million)
  • Table 33 Global Antibody Production Market, By Country/Region, 2022-2031 (USD Million)
  • Table 34 North America: Antibody Production Market, By Country, 2022-2031 (USD Million)
  • Table 35 North America: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 36 North America: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 37 North America: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 38 North America: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 39 North America: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 40 North America: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 41 North America: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 42 North America: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 43 U.S.: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 44 U.S.: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 45 U.S.: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 46 U.S.: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 47 U.S.: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 48 U.S.: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 49 U.S.: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 50 U.S.: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 51 Canada: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 52 Canada: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 53 Canada: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 54 Canada: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 55 Canada: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 56 Canada: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 57 Canada: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 58 Canada: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 59 Europe: Antibody Production Market, By Country, 2022-2031 (USD Million)
  • Table 60 Europe: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 61 Europe: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 62 Europe: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 63 Europe: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 64 Europe: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 65 Europe: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 66 Europe: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 67 Europe: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 68 Germany: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 69 Germany: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 70 Germany: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 71 Germany: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 72 Germany: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 73 Germany: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 74 Germany: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 75 Germany: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 76 France: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 77 France: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 78 France: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 79 France: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 80 France: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 81 France: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 82 France: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 83 France: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 84 U.K.: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 85 U.K.: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 86 U.K.: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 87 U.K.: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 88 U.K.: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 89 U.K.: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 90 U.K.: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 91 U.K.: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 92 Spain: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 93 Spain: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 94 Spain: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 95 Spain: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 96 Spain: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 97 Spain: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 98 Spain: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 99 Spain: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 100 Italy: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 101 Italy: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 102 Italy: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 103 Italy: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 104 Italy: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 105 Italy: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 106 Italy: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 107 Italy: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 108 RoE: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 109 RoE: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 110 RoE: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 111 RoE: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 112 RoE: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 113 RoE: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 114 RoE: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 115 RoE: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 116 Asia-Pacific: Antibody Production Market, By Country/Region, 2022-2031 (USD Million)
  • Table 117 Asia-Pacific: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 118 Asia-Pacific: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 119 Asia-Pacific: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 120 Asia-Pacific: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 121 Asia-Pacific: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 122 Asia-Pacific: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 123 Asia-Pacific: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 124 Asia-Pacific: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 125 China: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 126 China: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 127 China: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 128 China: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 129 China: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 130 China: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 131 China: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 132 China: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 133 Japan: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 134 Japan: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 135 Japan: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 136 Japan: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 137 Japan: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 138 Japan: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 139 Japan: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 140 Japan: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 141 RoAPAC: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 142 RoAPAC: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 143 RoAPAC: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 144 RoAPAC: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 145 RoAPAC: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 146 RoAPAC: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 147 RoAPAC: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 148 RoAPAC: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 149 Latin America: Antibody Production Market, By Country, 2022-2031 (USD Million)
  • Table 150 Latin America: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 151 Latin America: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 152 Latin America: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 153 Latin America: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 154 Latin America: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 155 Latin America: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 156 Latin America: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 157 Latin America: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 158 Brazil: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 159 Brazil: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 160 Brazil: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 161 Brazil: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 162 Brazil: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 163 Brazil: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 164 Brazil: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 165 Brazil: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 166 Mexico: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 167 Mexico: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 168 Mexico: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 169 Mexico: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 170 Mexico: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 171 Mexico: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 172 Mexico: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 173 Mexico: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 174 RoLATAM: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 175 RoLATAM: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 176 RoLATAM: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 177 RoLATAM: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 178 RoLATAM: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 179 RoLATAM: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 180 RoLATAM: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 181 RoLATAM: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 182 Middle East & Africa: Antibody Production Market, By Product, 2022-2031 (USD Million)
  • Table 183 Middle East & Africa: Antibody Production Instruments Market, By Type, 2022-2031 (USD Million)
  • Table 184 Middle East & Africa: Bioreactors for Antibody Production Market, By Type, 2022-2031 (USD Million)
  • Table 185 Middle East & Africa: Antibody Production Consumables Market, By Type, 2022-2031 (USD Million)
  • Table 186 Middle East & Africa: Antibody Production Market, By Antibody Type, 2022-2031 (USD Million)
  • Table 187 Middle East & Africa: Antibody Production Market, By Source, 2022-2031 (USD Million)
  • Table 188 Middle East & Africa: Antibody Production Market, By Process, 2022-2031 (USD Million)
  • Table 189 Middle East & Africa: Antibody Production Market, By End User, 2022-2031 (USD Million)
  • Table 190 Recent Developments, By Company, 2020-2023

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for This Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Antibody Production Market, By Product, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global Antibody Production Market, By Antibody Type, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Antibody Production Market, By Source, 2024 Vs. 2031 (USD Million)
  • Figure 10 Global Antibody Production Market, By Process, 2024 Vs. 2031 (USD Million)
  • Figure 11 Global Antibody Production Market, By End User, 2024 Vs. 2031 (USD Million)
  • Figure 12 Global Antibody Production Market, By Geography
  • Figure 13 Impact Analysis of Market Dynamics
  • Figure 14 Global Antibody Production Market, By Product, 2024 Vs. 2031 (USD Million)
  • Figure 15 Global Antibody Production Market, By Antibody Type, 2024 Vs. 2031 (USD Million)
  • Figure 16 Global Antibody Production Market, By Source, 2024 Vs. 2031 (USD Million)
  • Figure 17 Global Antibody Production Market, By Process, 2024 Vs. 2031 (USD Million)
  • Figure 18 Global Antibody Production Market, By End User, 2024 Vs. 2031 (USD Million)
  • Figure 19 Global Antibody Production Market, By Geography, 2024 Vs. 2031 (USD Million)
  • Figure 20 North America: Antibody Production Market Snapshot
  • Figure 21 Europe: Antibody Production Market Snapshot
  • Figure 22 Asia-Pacific: Antibody Production Market Snapshot
  • Figure 23 Latin America: Antibody Production Market Snapshot
  • Figure 24 Key Growth Strategies Adopted by Leading Players (2022-2024)
  • Figure 25 Antibody Production Market: Competitive Benchmarking, By Product
  • Figure 26 Antibody Production Market: Competitive Benchmarking, By Region
  • Figure 27 Competitive Dashboard Antibody Production Market
  • Figure 28 Global Antibody Production Market Share Analysis, By Key Players, 2024
  • Figure 29 Thermo Fisher Scientific, Inc.: Financial Overview (2024)
  • Figure 30 Merck KgaA.: Financial Overview (2024)
  • Figure 31 Eppendorf SE: Financial Overview (2024)
  • Figure 32 Agilent Technologies, Inc.: Financial Overview (2024)
  • Figure 33 Sartorius AG: Financial Overview (2024)
  • Figure 34 Danaher Corporation: Financial Overview (2024)
  • Figure 35 Waters Corporation: Financial Overview (2024)
  • Figure 36 Shimadzu Corporation: Financial Overview (2024)